FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075051827> ?p ?o ?g. }

• W2075051827 endingPage "e98336" @default.
• W2075051827 startingPage "e98336" @default.
• W2075051827 abstract "Enzyme replacement therapy (ERT) with recombinant human acid-α-glucosidase (rhGAA) is the only FDA approved therapy for Pompe disease. Without ERT, severely affected individuals (early onset) succumb to the disease within 2 years of life. A spectrum of disease severity and progression exists depending upon the type of mutation in the GAA gene (GAA), which in turn determines the amount of defective protein produced and its enzymatic activity. A large percent of the early onset patients are also cross reactive immunological material negative (CRIM-) and develop high titer immune responses to ERT with rhGAA. New insights from our studies in pre-clinical murine models reveal that the type of Gaa mutation has a profound effect on the immune responses mounted against ERT and the associated toxicities, including activation of clotting factors and disseminated intravascular coagulation (DIC). Additionally, the mouse strain affects outcomes, suggesting the influence of additional genetic components or modifiers. High doses of rhGAA (20 mg/kg) are currently required to achieve therapeutic benefit. Our studies indicate that lower enzyme doses reduce the antibody responses to rhGAA, reduce the incidence of immune toxicity and avoid ERT-associated anaphylaxis. Therefore, development of rhGAA with increased efficacy is warranted to limit immunotoxicities." @default.
• W2075051827 created "2016-06-24" @default.
• W2075051827 creator A5008285599 @default.
• W2075051827 creator A5018029184 @default.
• W2075051827 creator A5029214396 @default.
• W2075051827 creator A5034231492 @default.
• W2075051827 creator A5062727443 @default.
• W2075051827 creator A5064422415 @default.
• W2075051827 creator A5064705509 @default.
• W2075051827 creator A5086755266 @default.
• W2075051827 date "2014-06-04" @default.
• W2075051827 modified "2023-10-01" @default.
• W2075051827 title "Immune Responses and Hypercoagulation in ERT for Pompe Disease Are Mutation and rhGAA Dose Dependent" @default.
• W2075051827 cites W1911082026 @default.
• W2075051827 cites W1978067014 @default.
• W2075051827 cites W1981632300 @default.
• W2075051827 cites W1982261885 @default.
• W2075051827 cites W1989168301 @default.
• W2075051827 cites W1992387789 @default.
• W2075051827 cites W1994468264 @default.
• W2075051827 cites W2001810435 @default.
• W2075051827 cites W2008287871 @default.
• W2075051827 cites W2022042619 @default.
• W2075051827 cites W2022749609 @default.
• W2075051827 cites W2028778161 @default.
• W2075051827 cites W2035578076 @default.
• W2075051827 cites W2037050042 @default.
• W2075051827 cites W2037155515 @default.
• W2075051827 cites W2039001847 @default.
• W2075051827 cites W2045741878 @default.
• W2075051827 cites W2045817726 @default.
• W2075051827 cites W2047703405 @default.
• W2075051827 cites W2069344619 @default.
• W2075051827 cites W2069483072 @default.
• W2075051827 cites W2082991267 @default.
• W2075051827 cites W2091777991 @default.
• W2075051827 cites W2091858933 @default.
• W2075051827 cites W2094248743 @default.
• W2075051827 cites W2094355363 @default.
• W2075051827 cites W2098331662 @default.
• W2075051827 cites W2100199292 @default.
• W2075051827 cites W2132823811 @default.
• W2075051827 cites W2133695108 @default.
• W2075051827 cites W2141890696 @default.
• W2075051827 cites W2144392873 @default.
• W2075051827 cites W2145060571 @default.
• W2075051827 cites W2150843111 @default.
• W2075051827 cites W2152881917 @default.
• W2075051827 cites W2155825199 @default.
• W2075051827 cites W2158153222 @default.
• W2075051827 doi "https://doi.org/10.1371/journal.pone.0098336" @default.
• W2075051827 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4045583" @default.
• W2075051827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24897114" @default.
• W2075051827 hasPublicationYear "2014" @default.
• W2075051827 type Work @default.
• W2075051827 sameAs 2075051827 @default.
• W2075051827 citedByCount "23" @default.
• W2075051827 countsByYear W20750518272015 @default.
• W2075051827 countsByYear W20750518272016 @default.
• W2075051827 countsByYear W20750518272017 @default.
• W2075051827 countsByYear W20750518272019 @default.
• W2075051827 countsByYear W20750518272020 @default.
• W2075051827 countsByYear W20750518272021 @default.
• W2075051827 countsByYear W20750518272022 @default.
• W2075051827 countsByYear W20750518272023 @default.
• W2075051827 crossrefType "journal-article" @default.
• W2075051827 hasAuthorship W2075051827A5008285599 @default.
• W2075051827 hasAuthorship W2075051827A5018029184 @default.
• W2075051827 hasAuthorship W2075051827A5029214396 @default.
• W2075051827 hasAuthorship W2075051827A5034231492 @default.
• W2075051827 hasAuthorship W2075051827A5062727443 @default.
• W2075051827 hasAuthorship W2075051827A5064422415 @default.
• W2075051827 hasAuthorship W2075051827A5064705509 @default.
• W2075051827 hasAuthorship W2075051827A5086755266 @default.
• W2075051827 hasBestOaLocation W20750518271 @default.
• W2075051827 hasConcept C104317684 @default.
• W2075051827 hasConcept C126322002 @default.
• W2075051827 hasConcept C159654299 @default.
• W2075051827 hasConcept C203014093 @default.
• W2075051827 hasConcept C2779134260 @default.
• W2075051827 hasConcept C2779969927 @default.
• W2075051827 hasConcept C2780194698 @default.
• W2075051827 hasConcept C501734568 @default.
• W2075051827 hasConcept C54355233 @default.
• W2075051827 hasConcept C71924100 @default.
• W2075051827 hasConcept C86803240 @default.
• W2075051827 hasConcept C8891405 @default.
• W2075051827 hasConceptScore W2075051827C104317684 @default.
• W2075051827 hasConceptScore W2075051827C126322002 @default.
• W2075051827 hasConceptScore W2075051827C159654299 @default.
• W2075051827 hasConceptScore W2075051827C203014093 @default.
• W2075051827 hasConceptScore W2075051827C2779134260 @default.
• W2075051827 hasConceptScore W2075051827C2779969927 @default.
• W2075051827 hasConceptScore W2075051827C2780194698 @default.
• W2075051827 hasConceptScore W2075051827C501734568 @default.
• W2075051827 hasConceptScore W2075051827C54355233 @default.
• W2075051827 hasConceptScore W2075051827C71924100 @default.
• W2075051827 hasConceptScore W2075051827C86803240 @default.

• next